NIST, Applera, Bio-Rad, MJ Research, Stratagene, FDA, Epidauros Biotechnologie, Roche Molecular Systems, Third Wave, Caltech | GenomeWeb

NIST to Spend $6.3 Million to Improve Microarray Research

The National Institute of Standards and Technology will spend $6.25 million to develop a program aimed at identifying and addressing challenges in gene-expression measurement, validation, and quality control, NIST announced last week.

Over the next 5 years, the Metrology for Gene Expression Program will try to “improve the quality, reliability and comparability of gene expression measurements with microarrays,” NIST said in a statement.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.